PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy

Alhesa, A., Awad, H., Bloukh, S., Al-Balas, M., El-Sadoni, M., Qattan, D., Azab, B., & Saleh, T. (2022). PD-L1 expression in breast invasive ductal carcinoma with incomplete pathological response to neoadjuvant chemotherapy. International Journal of Immunopathology and Pharmacology, 36. https://doi.org/10.1177/03946320221078433
Authors:
Ahmad Alhesa
Heyam Awad
Sarah Bloukh
Mahmoud Al-Balas
Mohammed El‐Sadoni
Duaa Qattan
Belal Azab
Tareq Saleh
Affiliated Authors:
Belal Azab
Columbia Affiliation:
Subjects:
Cancer Immunotherapy (OpenAlex Topic)
Cancer Stem Cells and Tumor Metastasis (OpenAlex Topic)
Impact of Chronic Stress on Cancer Progression (OpenAlex Topic)
B7-H1 Antigen (MeSH)
Carcinoma, Ductal (MeSH)
Author Keywords:
breast cancer
programmed death-ligand 1
neoadjuvant chemotherapy
immunotherapy
pathological response
tumor infiltrating lymphocytes
overall survival
immunohistochemistry 22c3 pharmdx
elink
Publication Type:
Article
Unique ID:
10.1177/03946320221078433
PMID:
35225058
DOI:
10.1177/03946320221078433
Journal:
International Journal of Immunopathology and Pharmacology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View Scopus Record
View Web of Science Record

Record Created: